Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution
ConclusionsNeoadjuvant CHT with subsequent RARP may decrease the risk of BCR when compared to MIE-RP.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
More News: Cancer | Cancer & Oncology | Lower Endoscopy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Prostate Cancer | Statistics | Study | Urology & Nephrology